None listed
Conditions
Interventions
Behavioral : This study is a prospective, single-arm, interventional pilot study designed to evaluate the clinical effectiveness and utility of the diabetes management program ‘DT.E66’ over a 12-week
Sponsors
Kyung Hee University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adults aged 19 to 65 2) Individuals who were diagnosed with type 2 diabetes mellitus 3) Individuals who voluntarily agreed to participate in the study and signed the informed consent form for the study
Exclusion criteria
Exclusion criteria: 1) Individuals currently undergoing insulin therapy 2) Individuals with a BMI below 18.5 kg/m² or above 30.0 kg/m² 3) Individuals who have undergone treatment with anti-obesity medications, weight-loss drugs, or other weight-reduction therapies (e.g., surgery) within 3 months prior to enrollment 4) Individuals with systolic blood pressure =160 mmHg or diastolic blood pressure =100 mmHg (for those diagnosed with hypertension, blood pressure measured while on medication) 5) Individuals with AST, ALT, or creatinine levels more than twice the normal range 6) Individuals diagnosed with or currently receiving treatment for dementia, anxiety disorders, alcoholism, substance abuse, psychiatric disorders, autoimmune diseases, thyroid disorders, severe cerebrovascular diseases (e.g., stroke, cerebral hemorrhage), renal diseases (e.g., end-stage renal disease, dialysis), or cardiovascular diseases (e.g., angina, myocardial infarction, heart failure, arrhythmia) 7) Individuals who have been diagnosed with or treated for cancer within the past 5 years 8) Individuals with a history of major surgery within the past 6 months 9) Individuals currently undergoing hormone replacement therapy 10) Pregnant or lactating women, or women planning to become pregnant within the next 6 months 11) Individuals who participated in another clinical trial or human study within 1 month prior to this study 12) Individuals unable to read or with limited reading abilities. 13) Individuals unable to use mobile devices 14) Individuals deemed unsuitable for participation by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood profiles (FBG, Insulin, HOMA-IR, Total cholesterol, LDL-C, HDL-C, Triglyceride, CGM);SDSCA, Summary of Diabetes Self-Care Activities;EQ-5D-5L, The EuroQol-5 Dimensions-5 Levels | — |
Countries
Korea, Republic of
Contacts
Public ContactMinkyung Bok
Research Institute of Medical Nutrition
Outcome results
None listed